4.5 Review

The deadly cross-talk between Hippo pathway and epithelial-mesenchymal transition (EMT) in cancer

Related references

Note: Only part of the references are listed.
Review Medicine, Research & Experimental

Transcriptional co-activators YAP/TAZ: Potential therapeutic targets for metastatic breast cancer

Wenxia Zhao et al.

Summary: Breast cancer is the most commonly diagnosed cancer among women, with metastasis being the leading cause of death. Abnormal activation of YAP/TAZ in breast cancer leads to various effects on tumor promotion, and can affect metastasis-related processes and promote cancer progression. Advances in treatment options for YAP/TAZ-related breast cancer metastasis are being explored.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Oncology

HMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway

Jianxin Xu et al.

Summary: This study found that HMGA2 is highly expressed in TNBC cells, and downregulation of HMGA2 inhibits the migration and invasion of TNBC, as well as tumor metastasis in vivo, through suppression of EMT and the Hippo-YAP pathway.

CANCER BIOLOGY & THERAPY (2021)

Article Gastroenterology & Hepatology

Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer

Mingyang Liu et al.

Summary: The study revealed that ZIP4 activates ZEB1 and YAP1 to regulate pancreatic cancer metastasis and EMT plasticity, with significant impact on tumor progression and spread.

GASTROENTEROLOGY (2021)

Article Cell Biology

Distinct contributions of partial and full EMT to breast cancer malignancy

Fabiana Lueoend et al.

Summary: EMT is a transient and reversible process where cancer cells transition between epithelial and mesenchymal states. Partial EMT cells contribute to metastasis and chemoresistance, while full EMT cells fail to colonize the lungs but are enriched in recurrent tumors post-chemotherapy.

DEVELOPMENTAL CELL (2021)

Article Oncology

Catechol enhances chemo- and radio-sensitivity by targeting AMPK/Hippo signaling in pancreatic cancer cells

Jeong Yong Moon et al.

Summary: Research indicates that catechol can inhibit proliferation, promote apoptosis, reduce cell migration, invasion, and EMT, and enhance the chemo- and radio-sensitivity of Panc-1 cells by targeting the AMPK/Hippo signaling pathway.

ONCOLOGY REPORTS (2021)

Review Oncology

WWC Proteins: Important Regulators of Hippo Signaling in Cancer

Verena Hoffken et al.

Summary: The conserved Hippo pathway plays a crucial role in regulating cell proliferation and apoptosis through various mechanisms, essential for organ size control and tumor prevention. WWC proteins, as components and upstream regulators of the Hippo pathway, are often overlooked in their role in cancer development.

CANCERS (2021)

Article Oncology

Physical Interaction between HPV16E7 and the Actin-Binding Protein Gelsolin Regulates Epithelial-Mesenchymal Transition via HIPPO-YAP Axis

Paola Matarrese et al.

Summary: The study demonstrates that the interaction between HPV16 E7 and gelsolin promotes cytoskeleton rearrangement, leading to epithelial-mesenchymal transition and activating the HIPPO signaling pathway. This may play a role in the acquisition of a more aggressive phenotype in HPV16-transformed cells, providing potential therapeutic targets for HPV-related cancers.

CANCERS (2021)

Article Cell Biology

Upregulation of CD109 Promotes the Epithelial-to-Mesenchymal Transition and Stemness Properties of Lung Adenocarcinomas via Activation of the Hippo-YAP Signaling

Kang-Yun Lee et al.

Summary: CD109 is upregulated in metastatic lung adenocarcinoma cells, correlated with EMT traits in patients, and crucial for EMT gene expressions, tumor invasiveness, and cancer stemness properties. The elevation of CD109 is also associated with YAP signature in metastatic lung cancer cells, and YAP activation participates in CD109-induced EMT gene expressions and tumor invasiveness.

CELLS (2021)

Article Biochemistry & Molecular Biology

Phospholipase C Delta 3 inhibits apoptosis and promotes proliferation, migration, and invasion of thyroid cancer cells via Hippo pathway

Lizhi Lin et al.

Summary: In this study, PLCD3 was identified as an oncogene in thyroid cancer (TC), with high expression being associated with histological type, T stage, lymph node metastasis, and disease stage. Silencing PLCD3 inhibited TC cell colony formation, migration, and invasion, while promoting apoptosis. PLCD3 may be a potential target for TC treatment as it is associated with critical genes of the Hippo pathway.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2021)

Article Oncology

Blockage of glioma cell survival by truncated TEAD-binding domain of YAP

Wei Zhao et al.

Summary: The study demonstrates that YAPBD can inhibit the growth and migration of glioma cells by blocking the formation of the TEAD-YAP complex, inducing cell cycle arrest and apoptosis. Therefore, gene therapy targeting the TEAD-YAP complex may be a novel and promising approach for the treatment of malignant gliomas in humans.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

Article Oncology

Nuclear TEAD4 with SIX1 Overexpression is an Independent Prognostic Marker in the Stage I-III Colorectal Cancer

Tong Yu et al.

Summary: The study highlights the crucial role of TEAD4 and its direct target gene SIX1 in driving colorectal cancer progression, with their aberrant expression predicting poor prognosis in stage I-III CRC patients.

CANCER MANAGEMENT AND RESEARCH (2021)

Review Oncology

A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression

Hong-Li Li et al.

Summary: The Hippo pathway can promote tumor invasion and metastasis by regulating the expression of target genes. YAP/TAZ, as the core molecules of the Hippo pathway, interact with TEADs to regulate the expression of target genes related to tumor metastasis and invasion. Target genes induced by YAP/TAZ can lead to invasive pseudopodia formation, reduced intercellular adhesion, ECM degradation, EMT, or indirectly promote invasion and metastasis through other signaling pathways.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

Article Oncology

Upregulation of miR-1254 promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion via Inactivation of the Hippo-YAP signaling pathway by decreasing PAX5

Xu Lu et al.

Summary: miR-1254 is upregulated in HCC and promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of HCC cells by targeting PAX5 and regulating the Hippo signaling pathway. This miRNA may serve as a therapeutic target for HCC.

JOURNAL OF CANCER (2021)

Article Gastroenterology & Hepatology

Down-Regulation of LINC00460 Represses Metastasis of Colorectal Cancer via WWC2

Bao Yuan et al.

DIGESTIVE DISEASES AND SCIENCES (2020)

Article Oncology

TEAD2 as a novel prognostic factor for hepatocellular carcinoma

Jong Seok Joo et al.

ONCOLOGY REPORTS (2020)

Article Biochemistry & Molecular Biology

Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP-1 in breast cancer

Nora Feldker et al.

EMBO JOURNAL (2020)

Article Gastroenterology & Hepatology

The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa

Silvia Elena Molina-Castro et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Biotechnology & Applied Microbiology

miR-125a-5p inhibits colorectal cancer cell epithelial-mesenchymal transition, invasion and migration by targeting TAZ

Lei Tang et al.

ONCOTARGETS AND THERAPY (2019)

Review Oncology

The Hippo Signaling Pathway in Pancreatic Cancer

Daniel Ansari et al.

ANTICANCER RESEARCH (2019)

Review Cell Biology

Regulation of TEAD Transcription Factors in Cancer Biology

Hyunbin D. Huh et al.

CELLS (2019)

Article Biotechnology & Applied Microbiology

miR-520b Promotes Breast Cancer Stemness Through Hippo/YAP Signaling Pathway

Hui Zhang et al.

ONCOTARGETS AND THERAPY (2019)

Article Biochemistry & Molecular Biology

YAP and TAZ are essential for basal and squamous cell carcinoma initiation

Maud Debaugnies et al.

EMBO REPORTS (2018)

Review Biochemistry & Molecular Biology

E-cadherin in contact inhibition and cancer

Alisha M. Mendonsa et al.

ONCOGENE (2018)

Article Biotechnology & Applied Microbiology

WWC3 inhibits epithelial-mesenchymal transition of lung cancer by activating Hippo-YAP signaling

Qiang Han et al.

ONCOTARGETS AND THERAPY (2018)

Review Oncology

The transcriptional co-activator YAP: A new player in head and neck cancer

Carmen Segrelles et al.

ORAL ONCOLOGY (2018)

Article Biochemistry & Molecular Biology

A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer

L. A. Selth et al.

ONCOGENE (2017)

Article Cell Biology

WWC2 is an independent prognostic factor and prevents invasion via Hippo signalling in hepatocellular carcinoma

Yijun Zhang et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)

Review Pharmacology & Pharmacy

The Hippo Pathway as Drug Targets in Cancer Therapy and Regenerative Medicine

Shunta Nagashima et al.

CURRENT DRUG TARGETS (2017)

Review Oncology

YAP/TAZ at the Roots of Cancer

Francesca Zanconato et al.

CANCER CELL (2016)

Review Cell Biology

The roles of the Hippo pathway in cancer metastasis

Helena J. Janse van Rensburg et al.

CELLULAR SIGNALLING (2016)

Article Multidisciplinary Sciences

ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types

Waltraut Lehmann et al.

NATURE COMMUNICATIONS (2016)

Article Oncology

The role of transcriptional coactivator TAZ in gliomas

Weijie Li et al.

ONCOTARGET (2016)

Article Biochemistry & Molecular Biology

KRAS and YAP1 Converge to Regulate EMT and Tumor Survival

Diane D. Shao et al.

Article Biochemistry & Molecular Biology

The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells

Michelangelo Cordenonsi et al.

Article Multidisciplinary Sciences

E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components

Nam-Gyun Kim et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Biochemistry & Molecular Biology

TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition

Heng Zhang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Review Medicine, Research & Experimental

The basics of epithelial-mesenchymal transition

Raghu Kalluri et al.

JOURNAL OF CLINICAL INVESTIGATION (2009)

Article Biochemistry & Molecular Biology

TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway

Qun-Ying Lei et al.

MOLECULAR AND CELLULAR BIOLOGY (2008)

Article Multidisciplinary Sciences

Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon

Michael Overholtzer et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)